Dylan Adlard

Dylan joined the group in October 2020 and developed machine-learning models that used structural and chemical information to predict resistance to a first-line anti-TB compound.

He is currently studying for his DPhil as part of the SABS R³ programme having completed a 12 week rotation starting in April 2022 and then returning to start his DPhil project in October 2022.